查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495985

樣品製備市場 – 2024 年至 2029 年預測

Sample Preparation Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

2022 年樣品製備市場價值為 6,820,288,000 美元，預計複合年成長率為 4.89%，到 2029 年市場規模將達到 9,552,129,000 美元。

將化學和生物樣品轉化為可以直接插入儀器進行分析的形式的過程稱為樣品製備。樣品製備市場包括用於製備生物和化學樣品的產品，用於分析原料以檢測不需要的元素。樣品製備流程和產品廣泛應用於製藥領域、生物技術、實驗室、食品工業和化學工業。化學和生物領域的成長和進步正在推動樣品製備市場的成長。

樣品製備在藥物研究中的重要性和應用是全球樣品製備市場成長潛力的關鍵因素之一。與化學和生物學部分相關的所有調查和分析都得到適當的樣品製備過程和分析的支持。領先公司和政府為促進化學、生物和食品行業的研究和分析領域而進行的大量投資正在推動全球市場上樣品製備產品的市場規模。

小型化、自動化、高性能、新樣品製備設備與現有分析儀器整合的可能性、溶劑用量和時間的減少也正在推動全球市場樣品製備產品的市場規模。此外，在化學和生物研究中獲得準確結果的樣品分析效率也推動了樣品製備市場的成長。

製藥和化學領域新技術開發的主要市場參與企業之間的競爭也推動了樣品製備產品的市場規模，樣品製備產品對於在研究和實驗中獲得準確的結果發揮關鍵作用。政府的支持和製藥領域龍頭企業的資金活性化了疫情期間的研究活動，從而帶動了樣本製備市場的成長。

市場促進因素：

  • 樣品製備在藥物研究中日益重要，正在推動市場發展。

樣品製備過程在藥物研究中的關鍵作用是推動全球市場成長的關鍵因素之一。藥物分析是使用各種高性能分析儀器進行的，但大多數儀器不能直接處理複雜的基質，因此提取和分離感興趣的分析物的樣品製備步驟是很困難的。國際公司和政府機構對製藥和醫學研究的資助正在促進研究活動，並增加樣品製備產品的市場需求和價值。

英國製藥工業協會2017年的報告顯示，全球製藥業多年來在研發方面的投入，從2006年的1,081億美元增加到2016年的1,567億美元。製藥領域研究活動的不斷增加也擴大了與之相關的樣品製備市場的市場規模。

  • 健康和生物研究領域投資的增加預計將推動市場激增

對健康和生物研究領域的投資增加正在擴大全球市場上樣品製備產品的市場規模。 2018 年德國研究基金會 (DFG) 為德國定序中心提供的 1,730 萬美元資助是生物研究領域的投資之一。

亞太和中東地區新興國家在醫學研究領域的巨額投資預計也將在預計的幾年內擴大樣本製備市場的市場規模。

北美地區佔據了主要市場佔有率。

據估計，北美在樣品製備市場中佔據很大佔有率。美國是生物製藥的主要市場之一，在那裡進行的研發在北美地區佔據了很大的市場佔有率。由於其先進的醫療基礎設施、高研發活動、生物技術和製藥行業的存在、嚴格的監管標準以及對診斷測試和個性化醫療的關注，北美預計將在樣品製備市場中佔據很大佔有率。合作研究、生物樣本庫計畫、技術進步、生命科學研究資金增加、市場競爭。

該地區先進的醫療基礎設施、高研發活動、這些行業的存在以及嚴格的監管標準促進了複雜的樣品製備技術的採用。對診斷測試和個人化醫療的日益關注也推動了對準確、高效的樣品製備方法的需求。學術機構、研究中心和產業相關人員之間的合作將進一步加速尖端樣品製備技術的發展。北美樣品製備市場的競爭格局也刺激了市場的成長。

主要發展

  • 2023 年 1 月 - 科學家們開發了一種新方法來分析抑制Chaperone蛋白 HSP90 所造成的破壞，這是癌症治療的關鍵策略。利用多維蛋白質組學技術，我們對 HSP90 抑制的影響獲得了獨特的見解，檢測了蛋白質-蛋白質關聯的變化，並在清單中添加了新的蛋白質。這項認知將指南未來開發用於癌症治療的下一代 HSP90 抑制劑的努力，並加深我們對 HSP90 抑製作為健康老化策略潛力的理解。
  • 2022 年 10 月 - 沃特世公司推出 Extraction+ 連網型設備 ，這是一款適用於 Waters(TM) Andrew+(TM) 移液機器人的軟體控制產品，可透過固相萃取自動製備生物、食品、法醫學和環境樣品。這種免持的自動化方法使科學家能夠在每個樣品組上縮短時間的工作時間，並降低使用者變異的風險。該設備由智慧型幫浦、用於固定小柱或洗脫板的歧管以及用於在 SPE 淨化過程中創建和控制壓力梯度的軟體組成。 Waters 現已在全球提供 Extraction+Connected 設備。
  • 2022 年 10 月 - nRichDX 宣布推出兩款用於液態切片的新產品：革命循環遊離總核酸 (cfTNA) 試劑盒(TM) 和 cfDNA 參考標準產品。這些產品旨在幫助研究人員開發液態切片檢測方法，並與 nRichDX 的 Revolution Sample Prep System(TM) 相容。 Revolution 樣本製備系統用於從血漿或尿液樣本中提取高產量的稀有 cfDNA，這些樣本是液態切片檢測中使用的主要分析物。 cfDNA 參考標準品基於單核 DNA，包括一管 cfDNA 萃取對照品，可解凍並用於測量 cfDNA 萃取的產量和效率。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行概述

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章樣品製備市場：依產品

  • 介紹
  • 裝置
    • 市場機會和趨勢
    • 成長前景
    • 地理收益
    • 樣品製備工作站/系統
    • 液體處理系統
    • 萃取系統
    • 其他樂器
  • 消耗品
  • 樣品製備套件
  • 其他

第6章樣品製備市場：依應用分類

  • 介紹
  • 蛋白質體學
  • 基因組學
  • 表觀基因
  • 其他

第7章 樣品製備市場：依最終使用者分類

  • 介紹
  • 藥品
  • 生物技術
  • 臨床試驗診斷
  • 其他

第8章樣品製備市場：按地區

  • 介紹
  • 北美洲
  • 南美洲
  • 歐洲
  • 中東/非洲
  • 亞太地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Illumina
  • Merck Millipore（Merck KGaA）
  • Danaher Corporation
  • Roche
  • Perkinelmer, Inc.
  • Norgen Biotek Corporation
  • Qiagen NV
簡介目錄
Product Code: KSI061611954

The sample preparation market was evaluated at US$6,820.288 million for the year 2022 and is projected to grow at a CAGR of 4.89%, reaching a market size of US$9,552.129 million by the year 2029.

A process for converting chemical and biological samples into a form that can be directly inserted into an instrument for analysis is termed sample preparation. The sample preparation market includes products that are used to prepare biological and chemical samples to analyze raw materials to detect undesirable elements. Sample preparation processes and products are widely used in the pharmaceutical sector, biotechnology, laboratories, food industry, and chemical industry. The growth and progress in the chemical and biological sectors are promoting the sample preparation market growth.

The importance and application of sample preparation in pharmaceutical research are one of the major factors giving potential to the global sample preparation market growth. Every research and analysis associated with the chemical and biological sector is supported by a proper sample preparation process and analysis. The large investments of major companies and governments in promoting the research and analysis sector of the chemical, biological, and food industries is boosting the market value of sample preparation products in the global market.

Miniaturization, automation, high-throughput performance, the potential of new sample preparation instruments to integrate with existing analytical instruments, and a reduction in solvent volume and time are also pushing the market value of sample preparation products in the global market. The efficiency showcased by sample analysis in giving accurate results in chemical and biological research is also fuelling the sample preparation market growth.

The competition of major market players for developing new technologies in the pharmaceutical and chemical field is also hiking the market value of sample preparation products, as they have a vital role in giving accurate results in research and experiments. The support offered by the government and funds offered by major players in the pharmaceutical field fuelled the research activities during the pandemic period, resulting in the sample preparation market growth.

Market Drivers:

  • The rising importance of sample preparation in pharmaceutical research poses to propel the market.

The vital role of the sample preparation process in pharmaceutical research is one of the major factors driving its market growth globally. Pharmaceutical analyses are performed utilizing various high-performance analytical instruments, even though most analytical devices cannot directly handle complex matrixes, necessitating a sample preparation step to extract and isolate the analytes of interest. The funding given for pharmaceutical and medical research by international companies and governmental organizations is boosting research activities, which also increases the market demand and value for sample preparation products.

According to a 2017 report by the Association of the British Pharmaceutical Industry, the global pharmaceutical industry has invested in research and development over the years, from USD 108.1 billion in 2006 to USD 156.7 billion in 2016. The increasing rate of research activities in the pharmaceutical field is also hiking the market value of the sample preparation market associated with it.

  • Increasing investments in the health and biological research sector are expected to surge the market.

The increasing investments in the health and biological research sector are hiking the market value of sample preparation products in the global market. The funding of 17.3 million USD by the German Research Foundation (DFG) in 2018 for German sequencing centers is one of the investments in the biological research sector.

The significant investments made by developing countries in the Asia Pacific and the Middle East region in the medical and healthcare research sector are also expected to push the market value of the sample preparation market in the forecasted years.

The North American region holds a major share of the market.

North America is estimated to hold a significant market share in the sample preparation market. As the United States is one of the major markets for biopharmaceuticals, the research, and developments taking place in the country contributed to the large market share of the North American region. North America is expected to hold a significant share of the sample preparation market due to its advanced healthcare infrastructure, high research and development activities, presence in the biotechnology and pharmaceutical industries, strict regulatory standards, increasing focus on diagnostic testing and personalized medicine, collaborations, biobanking initiatives, technological advancements, increased funding for life sciences research, and market competitiveness.

The region's advanced healthcare infrastructure, high research and development activities, presence of these industries, and strict regulatory standards contribute to the adoption of sophisticated sample preparation technologies. The growing focus on diagnostic testing and personalized medicine also drives the demand for accurate and efficient sample preparation methods. Collaborations between academic institutions, research centers, and industry players further foster the development of cutting-edge sample preparation technologies. The competitive landscape in the North American sample preparation market also stimulates market growth.

Key Developments:

  • January 2023- Scientists developed a new method to analyze the disruption caused by inhibiting the chaperone protein HSP90, a key strategy for cancer treatment. They used a multi-dimensional proteomic technique to gain a unique view of the effects of HSP90 inhibition, detecting changes in protein-protein associations and adding new proteins to the list. This understanding guides future efforts to develop next-generation HSP90 inhibitors for cancer treatment and advance our understanding of HSP90 inhibition's potential as a strategy for healthier aging. HSP90 is crucial for stabilizing or activating around 300 proteins in cells, many of which are oncogenic.
  • October 2022- Waters Corporation launched the Extraction+ connected device, a software-controlled product for the Waters(TM) Andrew+(TM) Pipetting Robot, which automates the preparation of biological, food, forensics, and environmental samples via solid phase extraction. This hands-free, automated approach saves scientists up to four hours of bench time for each sample set and reduces the risk of user-to-user variability. The device consists of a smart pump, a manifold for holding cartridges or elution plates, and software for creating and controlling pressure gradients during SPE cleanup procedures. The Extraction+ Connected Device is now available worldwide from Waters.
  • October 2022- nRichDX introduced two new products for liquid biopsy applications: the Revolution Circulating Free Total Nucleic Acid (cfTNA) Kit(TM) and the cfDNA Reference Standard products. These products are designed to aid researchers in developing liquid biopsy assays and are compatible with nRichDX's Revolution Sample Prep System(TM). The Revolution Sample Prep System is used for high-yield extraction of rare cfDNA from plasma or urine samples, which is the primary analyte used in liquid biopsy assays. The cfDNA Reference Standard, based on mono-nucleosomal DNA, contains tubes of thaw-and-use cfDNA extraction controls to measure the yield and efficiency of cfDNA extraction.

Segmentation:

By Product

  • Instruments
  • Sample Preparation Workstations/Systems
  • Liquid Handling Systems
  • Extraction Systems
  • Other Instruments
  • Consumables
  • Sample Preparation Kits
  • Other Products

By Application

  • Proteomics
  • Genomics
  • Epigenomics
  • Others

By End Users

  • Pharmaceuticals
  • Biotechnology
  • Laboratory Diagnostics
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. SAMPLE PREPARATION MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Instruments
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
    • 5.2.4. Sample Preparation Workstations/Systems
    • 5.2.5. Liquid Handling Systems
    • 5.2.6. Extraction Systems
    • 5.2.7. Other Instruments
  • 5.3. Consumables
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Sample Preparation Kits
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Other Products
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness

6. SAMPLE PREPARATION MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Proteomics
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Genomics
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Epigenomics
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. SAMPLE PREPARATION MARKET BY END USERS

  • 7.1. Introduction
  • 7.2. Pharmaceuticals
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Biotechnology
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Laboratory Diagnostics
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness
  • 7.5. Others
    • 7.5.1. Market Opportunities and Trends
    • 7.5.2. Growth Prospects
    • 7.5.3. Geographic Lucrativeness

8. SAMPLE PREPARATION MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End Users
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Product
    • 8.3.2. By Application
    • 8.3.3. By End Users
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Product
    • 8.4.2. By Application
    • 8.4.3. By End Users
    • 8.4.4. By Country
      • 8.4.4.1. Germany
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. France
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. UK
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Others
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Product
    • 8.5.2. By Application
    • 8.5.3. By End Users
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Product
    • 8.6.2. By Application
    • 8.6.3. By End Users
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. India
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. Japan
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Taiwan
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Indonesia
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects
      • 8.6.4.8. Others
        • 8.6.4.8.1. Market Opportunities and Trends
        • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Agilent Technologies Inc.
  • 10.2. Bio-Rad Laboratories Inc.
  • 10.3. Illumina
  • 10.4. Merck Millipore (Merck KGaA)
  • 10.5. Danaher Corporation
  • 10.6. Roche
  • 10.7. Perkinelmer, Inc.
  • 10.8. Norgen Biotek Corporation
  • 10.9. Qiagen N.V